GENE ONLINE|News &
Opinion
Blog

2025-04-03|

AI and 3D Printing Boost Generic Drug Development, Expanding Formulation Possibilities

by Mark Chiang
Share To

Technological advancements are reshaping the generic drug industry, leading to faster development times and improved drug quality. The integration of artificial intelligence and 3D printing are playing key roles in this transformation, according to a recent report. AI algorithms now analyze extensive datasets to pinpoint potential targets for generic drug development, while machine learning algorithms predict the efficacy and safety of new compounds. Furthermore, 3D printing technology enables the creation of complex drug formulations previously unattainable. This opens avenues for personalized medicine and expands the possibilities within generic drug development. As a result of these advancements, the number of available generic medications is expected to increase, potentially benefiting patients and healthcare systems worldwide.

Newsflash | Powered by GeneOnline AI
Source: https://www.drugpatentwatch.com/blog/the-impact-of-technological-advances-on-generic-drug-development/ Thu, 03 Apr 2025 04:19:40 +0000

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Study Finds Limited Evidence Linking Exercise to Changes in SASP Biomarkers in Older Adults
2026-02-08
Eco-Friendly Zinc Nanoparticles Synthesized Using Beetroot Peel Extract Show Antibacterial and Photocatalytic Properties
2026-02-08
Abaxx Exchange to Integrate with TMX Trayport’s Joule Platform for Enhanced Trading Access
2026-02-08
Luckin Coffee Opens 30,000th Store with Launch of Origin Flagship Location
2026-02-08
Study Finds Nitazene-Linked Deaths in UK Underreported by 33 Percent
2026-02-08
ICE Launches FTSE South Korea RIC Capped Index Futures on February 9, 2026
2026-02-08
New Model Maps Pedestrian Foot Traffic Across New York City During Peak Travel Periods
2026-02-08
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top